Reaction profile

The FDA adverse-event record for pr-multiple sites, blood

47 FDA reports name pr-multiple sites, blood, a lower-volume reaction in the CVM extract (VeDDRA 99643). Plate stamps and neighbourhood peers follow.

#1776 of 2,481
by report volume (all reactions)
47
reports citing this reaction
100.0%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. PR-MULTIPLE SITES, BLOOD has 47 reports now versus 47 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to PR-MULTIPLE SITES, BLOOD changes

FDA AER · VeDDRA plate

Code 99643 VOL-TRACE

VOL-TRACE · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 47 reports
  • DEATH-HOT 100.0%
  • MID-PACK #1776/2481
  • PHOTO-FINISH Abnormal number of of…
  • SPECIES-DOG Dog · 23
  • DRUG-LEAD Moxidectin · 5
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal number of offspring (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around PR-MULTIPLE SITES, BLOOD

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abnormal number of of… · near47ALBUMIN/GLOBULIN RATI… · near47ANISOCYTOSIS · near47Blood in trachea · near47PR-MULTIPLE SITES, BL… · thi…47Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around PR-MULTIPLE SITES, BLOOD

PR-MULTIPLE SITES, BLOOD: high death-coded share in the FDA AER plate

Signature read: PR-MULTIPLE SITES, BLOOD's 100.0% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 47 named reports in the openFDA extract. Death-coded share is upper-third: 47 of 47 reports (100.0% of named reports). Nearest volume peer: Abnormal number of offspring (±0 reports). Lead species Dog (23). Lead co-reported drug Moxidectin (5).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 23
Cat 15
Cattle 5
Horse 4

Breeds Most Affected

Domestic (unspecified) 10
Domestic Shorthair 4
Cattle (unknown) 3
Appaloosa 2
Crossbred Canine/dog 2
Retriever - Labrador 2
Crossbred Bovine/Cattle 1
Aberdeen Angus 1
Horse (other) 1
Dog (unknown) 1

Associated Drugs

Moxidectin 5
Carprofen 5
Cefovecin Sodium 5
Maropitant Citrate 4
Meloxicam 3
Maropitant 3
Cefovecin 3
Dexamethasone 3
Xylazine 2
Dexmedetomidine Hydrochloride 2
Anesthetic 2
Toceranib Phosphate 2
Diphenhydramine Hcl 2
Plasma 2
Diazepam 2
Afoxolaner 2
Butorphanol Tartrate 1
Imidacloprid, Moxidectin 1
Praziquantel 1
Ivermectin 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for PR-MULTIPLE SITES, BLOOD (#1776 of 2,481 by report volume); death-coded 100.0%. PlainBreed reaction plate · death-coded share stamp 100.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →